CN1059578C - Medicine for treating cholelithiosis (stone-removing powder medicine) - Google Patents
Medicine for treating cholelithiosis (stone-removing powder medicine) Download PDFInfo
- Publication number
- CN1059578C CN1059578C CN96115837A CN96115837A CN1059578C CN 1059578 C CN1059578 C CN 1059578C CN 96115837 A CN96115837 A CN 96115837A CN 96115837 A CN96115837 A CN 96115837A CN 1059578 C CN1059578 C CN 1059578C
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- medicine
- cholelithiasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating cholelithiasis. The present invention is mainly characterized in that the medicine contains 20 parts of virgate wormwood herb, 12 parts of bupleurum root, 10 parts of curcuma, 10 parts of pangolin scale, 6 parts of costus root, 15 parts of orange fruit, 10 parts of chicken's gizzard-membrane, 20 parts of longhairy antenoron herb, 10 parts of white peony alba, 0.2 part of gallstone and 5 parts of magnesium sulfate. The present invention which can effectively treat cholelithiasis has the advantages of good curative effect and no complication or relapse and can be widely used in clinical application.
Description
The present invention relates to a kind of medicine, exactly is a kind of medicine of the treatment cholelithiasis that mainly is made into by Chinese medicine.
At present, along with medical development, method, the means of treatment cholelithiasis are more and more, mainly contain medicine lithodialysis, calculus, mechanical lithotripsy and surgical calculus removing.The surgical calculus removing of doctor trained in Western medicine, particularly to than maximum size and some serious syndrome patient, be still effective treatment means, but surgical calculus removing has remained following problem: the one, the postoperative calculus is residual to have rate still at 10-25%, causes the patient to be reluctant maybe should not to accept repeatedly operation; The 2nd, easily produce post-operative complication, be about 15%; The 3rd, to some particular patients ', the existence of operative mortality is about 0.3-3%.Particularly calculus of intrahepatic duct is still a difficult problem in the surgical operation,, has operation risk because higher complication rate (13%) and mortality rate (5%) are arranged; The 4th, the cholelithiasis relapse rate is higher, can not depend merely on operation method and solve.In recent years, treatment around cholelithiasis, constantly explore new Therapeutic Method both at home and abroad, as by Wu Xintong, still " Chinese and Western cure cholelithiasis urinary calculus " book (in April, 93 front page) of writing such as Linzhou, Song Jingfan is gone up and is introduced, Mayo, Rochester, Minn. medical clinic is with methyl---and tertbutyl ether is expelled to and directly dissolves calculus in patient's gallbladder, cure rate 95%, this is that cure rate is higher up to now, but this method complexity, also do not have several families can carry out this method at present abroad, and this method only is applicable to as yet the cholesterol microlith of not calcification.The Chinese traditional treatment cholelithiasis has long history, Chinese medicine, acupuncture, ear pressure, dietetic therapy, therapy of combining Chinese and Western medicine in recent years, cholelithiasis is all had certain curative effect, but a common issue with of its existence is that bile duct can not effectively be expanded, and has influenced the curative effect to cholelithiasis.
The objective of the invention is to develop a kind of, can effectively reduce complication and relapse rate, the medicine of the treatment cholelithiasis that therapeutic effect is good, cure rate is high based on Chinese medicine.
The present invention realizes as follows:
The medicine of treatment cholelithiasis, it is characterized in that containing Herba Artemisiae Scopariae in the described medicine, Radix Bupleuri, Radix Curcumae, Squama Manis, Radix Aucklandiae (Radix Vladimiriae), Fructus Aurantii, Endothelium Corneum Gigeriae Galli, Herba Lysimachiae, the Radix Paeoniae Alba, also contain cholelithiasis, magnesium sulfate, weight proportion in above-mentioned every pharmaceutical unit dosage form is followed successively by: 20: 12: 10: 10: 6: 15: 10: 20: 10: 0.2: 5, wherein said Herba Artemisiae Scopariae content is 20 parts, 12 parts of Radix Bupleuri, 10 parts of Radix Curcumaes, 10 parts of Squama Maniss, 6 parts of Radix Aucklandiae (Radix Vladimiriae), 15 parts of Fructus Aurantiis, 10 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Herba Lysimachiaes, 10 parts of the Radix Paeoniae Albas, described cholelithiasis content is 0.2 part, 5 parts in magnesium sulfate, the above-mentioned medicament mixed that everybody makes powder promptly.
The medicine of described treatment cholelithiasis, it is to make with the raw material of following consumption: described Herba Artemisiae Scopariae 20 grams, Radix Bupleuri 12 grams, Radix Curcumae 10 grams, Squama Manis 10 grams, Radix Aucklandiae (Radix Vladimiriae) 6 grams, Fructus Aurantii 15 grams, Endothelium Corneum Gigeriae Galli 10 grams, Herba Lysimachiae 20 grams, the Radix Paeoniae Alba 10 grams, also contain cholelithiasis 0.2 gram, magnesium sulfate 5 grams.
Cholelithiasis is commonly considered as being caused by the strongly fragrant stagnation of QI of gallbladder, the tired spleen of phlegm-damp, damp-heat in middle-JIAO, stagnation of blood stasis and malnutrition due to parasitic infestation etc. on the traditional Chinese medical science, and the gallbladder internal organs is obstructed, influences bile to carry, and bile is stopped up resistance, the stasis knot gathers into stone.Based on above-mentioned theory, in this medicine, get the usefulness that Radix Bupleuri, Radix Curcumae, Radix Aucklandiae (Radix Vladimiriae), Fructus Aurantii are made the depressed liver-energy dispersing and QI regulating resolving depression; Get Herba Lysimachiae, Herba Artemisiae Scopariae removing dampness-heat in the liver and gallbladder; Get Endothelium Corneum Gigeriae Galli, Radix Paeoniae Alba softening hardness and resolving stasis, easing the affected liver yin fluid astringing; Get magnesium sulfate and capture purging FU-organs; Further strengthen the ability of adding medicine to away and scurrying with Squama Manis, cholelithiasis.Described cholelithiasis is the calculus of coagulating on liver and gall, and promptly the calculus that operation is taken out or medicine is discharged has heat-clearing and toxic substances removing, the effect of inducing menstruation to relieve menalgia.This medicine given full play to Chinese medicine can through advantage, hepatic secretion bile increased, gallbladder shrinks, cystic duct, common bile duct and oddis sphincter are in expansion state in good time, increase the bile excretion amount of unit interval, the purging FU-organs of regulating the flow of vital energy, relieving spasm to stop pain is removed cholepathia spastica, promotes the molten row of calculus.
When taking this medicine, every medicine mix homogeneously is processed into powder, make powder, clinical in patient body's system, the 100-150 that gets it filled gram adds 500 milliliters in water, and 20-30 at a simmer minute, fry in shallow oil 2 times for every dose, get 200 milliliters of filtrates, ante cibum, decoction being taken warmly got final product sooner or later.
The present invention compared with prior art has the following advantages: the one, to compare with similar Drug therapy, and treatment cycle is short, takes medicine and can take effect in one month; The 2nd, therapeutic effect is good, the cure rate height, and according to 100 routine clinical observations, effective percentage reaches 98.2%, lithagogue rate 96%, recent free rate 39%, maximum can be discharged 2.2 * 2.0 centimetres calculus; The 3rd, no complication and rebound phenomenon face art and do not find such patient of example as yet, have reduced patient's misery and medical expense.
Existing two embodiments of the invention of enumeration:
Embodiment 1: contain Herba Artemisiae Scopariae, Radix Bupleuri, Radix Curcumae, Squama Manis, Radix Aucklandiae (Radix Vladimiriae), Fructus Aurantii, Endothelium Corneum Gigeriae Galli, Herba Lysimachiae, the Radix Paeoniae Alba in the medicine of treatment cholelithiasis, also contain cholelithiasis, magnesium sulfate, wherein Herba Artemisiae Scopariae 20 restrains, Radix Bupleuri 12 restrains, Radix Curcumae 10 restrains, Squama Manis 10 restrains, Radix Aucklandiae (Radix Vladimiriae) 6 restrains, Fructus Aurantii 15 restrains, Endothelium Corneum Gigeriae Galli 10 restrains, Herba Lysimachiae 20 restrains, the Radix Paeoniae Alba 10 restrains, also contain cholelithiasis 0.2 gram, magnesium sulfate 5 grams, promptly with the above-mentioned medicament mixed that everybody makes powder.
Embodiment 2: the medicine of treatment cholelithiasis, get Herba Artemisiae Scopariae 40 grams, Radix Bupleuri 24 grams, Radix Curcumae 20 grams, Squama Manis 20 grams, Radix Aucklandiae (Radix Vladimiriae) 12 grams, Fructus Aurantii 30 grams, Endothelium Corneum Gigeriae Galli 20 grams, Herba Lysimachiae 40 grams, the Radix Paeoniae Alba 20 grams, cholelithiasis 0.4 gram, magnesium sulfate 10 grams, every medicine is made powder mixes promptly.
Claims (2)
1, a kind of medicine for the treatment of cholelithiasis is characterized in that it is that following column weight amount proportion raw material is made: 20 parts of Herba Artemisiae Scopariaes, 12 parts of Radix Bupleuri, 10 parts of Radix Curcumaes, 10 parts of Squama Maniss, 6 parts of Radix Aucklandiae (Radix Vladimiriae), 15 parts of Fructus Aurantiis, 10 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Herba Lysimachiaes, 10 parts of the Radix Paeoniae Albas, 0.2 part of cholelithiasis, 5 parts in magnesium sulfate.
2, according to the medicine of the described treatment cholelithiasis of claim 1, it is characterized in that it is to make with the raw material of following consumption: Herba Artemisiae Scopariae 20 grams, Radix Bupleuri 12 grams, Radix Curcumae 10 grams, Squama Manis 10 grams, Radix Aucklandiae (Radix Vladimiriae) 6 grams, Fructus Aurantii 15 grams, Endothelium Corneum Gigeriae Galli 10 grams, Herba Lysimachiae 20 grams, the Radix Paeoniae Alba 10 grams, cholelithiasis 0.2 gram, magnesium sulfate 5 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115837A CN1059578C (en) | 1996-06-13 | 1996-06-13 | Medicine for treating cholelithiosis (stone-removing powder medicine) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96115837A CN1059578C (en) | 1996-06-13 | 1996-06-13 | Medicine for treating cholelithiosis (stone-removing powder medicine) |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1168797A CN1168797A (en) | 1997-12-31 |
CN1059578C true CN1059578C (en) | 2000-12-20 |
Family
ID=5123047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96115837A Expired - Fee Related CN1059578C (en) | 1996-06-13 | 1996-06-13 | Medicine for treating cholelithiosis (stone-removing powder medicine) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1059578C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100346821C (en) * | 2005-10-17 | 2007-11-07 | 胡进前 | Medicinal capsule for treating liver and gallbladder diseases and its preparing process |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491206A (en) * | 2015-01-15 | 2015-04-08 | 王金强 | Traditional Chinese medicine preparation for treating calculus of bile duct and preparation method thereof |
-
1996
- 1996-06-13 CN CN96115837A patent/CN1059578C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
河北中医1994,16(6) 1994.6.30 中西医结合治疗胆石症100例临床观察 * |
河北中医1994,16(6) 1994.6.30 中西医结合治疗胆石症100例临床观察;湖北中医杂志1983,(2) 1983.2.28 肖海波,柴茵金合剂治疗胆囊炎胆石症 * |
湖北中医杂志1983,(2) 1983.2.28 肖海波,柴茵金合剂治疗胆囊炎胆石症 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100346821C (en) * | 2005-10-17 | 2007-11-07 | 胡进前 | Medicinal capsule for treating liver and gallbladder diseases and its preparing process |
Also Published As
Publication number | Publication date |
---|---|
CN1168797A (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
CN101062372A (en) | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi | |
CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
CN101167998B (en) | Traditional Chinese medicine pill for treating gynopathy and preparation method thereof | |
CN1059578C (en) | Medicine for treating cholelithiosis (stone-removing powder medicine) | |
CN100457168C (en) | A traditional Chinese medicine for treating prostate diseases | |
CN1357357A (en) | Blood circulation activating capsule for treating bone injury and its prepn process | |
CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
CN101708292B (en) | Chinese medicament for treating rheumatic and rheumatoid diseases | |
CN1218708C (en) | Chinese medicine prescription for curing eye disease and its preparation method | |
CN1876058A (en) | A medicine for treating ankylosing spondylitis and preparation method thereof | |
CN100398143C (en) | Medicament for treating vitiligo | |
CN1586524A (en) | External medicine for treating lithiasis | |
CN1679686A (en) | Capsules for treating prostatic disease | |
CN1054052C (en) | Comedo-elimination preparation | |
CN113491739B (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
CN102698126B (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof | |
CN101288760B (en) | Externally-used drug for treating appendicitis | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
CN1277552C (en) | Five ingredients kaladana containing capsule and preparation technique thereof | |
CN1166985A (en) | Capsule for curing mammary gland hyperplasis | |
CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
CN1176676C (en) | Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process | |
CN1121827A (en) | "Jinshisan" powder for treatment of gallstones and lithangiuria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |